Устойчивость к антидепрессантам: почему возникает и что с этим делать?
- Авторы: Цыбко А.С1
-
Учреждения:
- Институт цитологии и генетики СО РАН
- Выпуск: № 2 (2023)
- Страницы: 3-15
- Раздел: Статьи
- URL: https://journals.eco-vector.com/0032-874X/article/view/627778
- DOI: https://doi.org/10.7868/S0032874X23020011
- ID: 627778
Цитировать
Полный текст
Открытый доступ
Доступ предоставлен
Доступ платный или только для подписчиков
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Устойчивость к антидепрессантам — один из самых больших вызовов для современной нейрофармакологии. В статье предлагается взглянуть на проблему с точки зрения серотониновой системы. Каковы ее особенности и как они могут обуславливать терапевтическую резистентность? Кроме того, отдельное внимание уделено рецепторам серотонина, удивительная биология которых не только проливает свет на механизмы депрессивных расстройств, но и обещает дать ключ к их эффективной терапии.
Ключевые слова
Об авторах
А. С Цыбко
Институт цитологии и генетики СО РАН
Email: antoncybko@mail.ru
Новосибирск, Россия
Список литературы
- Kendall K.M., Van Assche E., Andlauer T.F.M. et al. The genetic basis of major depression. Psychol. Med. 2021; 51: 2217–2230. doi: 10.1017/S0033291721000441.
- Maffioletti E., Minelli A., Tardito, D. et al. Blues in the brain and beyond: molecular bases of major depressive disorder and relative pharmacological and non-pharmacological treatments. Genes (Basel). 2020; 11(9): 1089. doi: 10.3390/genes11091089.
- Halaris A., Sohl E., Whitham E.A. Treatment-resistant depression revisited: A Glimmer of Hope. J. Pers. Med. 2021; 11(2): 155. doi: 10.3390/jpm11020155.
- Olivier B. Serotonin: A never-ending story. Eur. J. Pharmacol. 2015; 753: 2–18. doi: 10.1016/j.ejphar.2014.10.031.
- Ren J., Friedmann D., Xiong J. et al. Anatomically defined and functionally distinct dorsal raphe serotonin sub-systems. Cell. 2018; 175(2): 472–487.e20. doi: 10.1016/j.cell.2018.07.043.
- Mann J.J., Huang Y.Y., Underwood M.D. et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry. 2000; 57(8): 729–738. doi: 10.1001/archpsyc.57.8.729.
- Austin M.C., Whitehead R.E., Edgar C.L. et al. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience. 2002; 114(3): 807–815. doi: 10.1016/s0306-4522(02)00289-0.
- Underwood M.D., Kassir S.A., Bakalian M.J. et al. Neuron density and serotonin receptor binding in prefrontal cortex in suicide. Int. J. Neuropsychopharmacol. 2012; 15(4): 435–447. doi: 10.1017/S1461145711000691.
- Rajkowska G., Mahajan G., Legutko B. et al. Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression. Neuroscience. 2017; 359: 30–39. doi: 10.1016/j.neuroscience.2017.07.006.
- Albert P.R., Vahid-Ansari F., Luckhart C. Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression. Front. Behav. Neurosci. 2014; 8: 199. doi: 10.3389/fnbeh.2014.00199.
- Sharp T., Boothman L., Raley J., Quérée P. Important messages in the “Post”: Recent Discoveries in 5-HT Neurone Feedback Control. Trends Pharmacol. Sci. 2007; 28(12): 629–636, doi: 10.1016/j.tips.2007.10.009.
- Kempermann G., Gage F.H., Aigner L. et al. Human adult neurogenesis: evidence and remaining questions. Cell Stem Cell. 2018; 23(1): 25–30, doi: 10.1016/j.stem.2018.04.004.
- Klempin F., Babu H., De Pietri Tonelli D. et al. Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis. Front. Mol. Neurosci. 2010; 3: 14. doi: 10.3389/fnmol.2010.00014.
- Samuels B.A., Anacker C., Hu A. et al. 5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response. Nat. Neurosci. 2015; 18(11): 1606–1616. doi: 10.1038/nn.4116.
- Zanderigo F., Pantazatos S., Rubin-Falcone H. et al. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder. Brain Struct. Funct. 2018; 223(6): 2609–2625. doi: 10.1007/s00429-018-1649-6.
- Maroteaux L., Béchade C., Roumier A. Dimers of serotonin receptors: impact on ligand affinity and signaling. Biochimie. 2019; 161: 23–33. doi: 10.1016/j.biochi.2019.01.009.
- Borroto-Escuela D.O., Li X., Tarakanov A.O. et al. Existence of brain 5-HT1A-5-HT2A isoreceptor complexes with antagonistic allosteric receptor-receptor interactions regulating 5-HT1A receptor recognition. ACS Omega. 2017; 2(8): 4779–4789. doi: 10.1021/acsomega.7b00629.
- Naumenko V.S., Popova N.K., Lacivita E. et al. Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders. CNS Neurosci. Ther. 2014; 20: 582–590. doi: 10.1111/cns.12247.
- Rodnyy A.Y., Kondaurova E.M., Bazovkina D.V. et al. Serotonin 5-HT(7) receptor overexpression in the raphe nuclei area produces antidepressive effect and affects brain serotonin system in male mice. J. Neurosci. Res. 2022; 100: 1506–1523. doi: 10.1002/jnr.25055.
- Ilchibaeva T., Tsybko A., Zeug A. et al. Serotonin receptor 5-HT(2A) regulates TrkB receptor function in heteroreceptor complexes. Cells. 2022; 11(15): 2384. doi: 10.3390/cells11152384.
- Barnes N.M., Ahern G.P., Becamel C. et al. International union of basic and clinical pharmacology. CX. Classification of Receptors for 5-Hydroxytryptamine; Pharmacology and Function. Pharmacol. Rev. 2021; 73(11): 310–520. doi: 10.1124/pr.118.015552.
- Gorinski N., Bijata M., Prasad S. et al. Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors. Nat. Commun. 2019; 10(1): 3924. doi: 10.1038/s41467-019-11876-5.
- Vahid-Ansari F., Zhang M., Zahrai A., Albert P.R. Overcoming resistance to selective serotonin reuptake inhibitors: targeting serotonin, serotonin-1A receptors and adult neuroplasticity. Front. Neurosci. 2019; 13: 404. doi: 10.3389/fnins.2019.00404.
- Albert P.R., Le François B., Vahid-Ansari F. Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm. J. Psychiatry Neurosci. 2019; 44: 164–176. doi: 10.1503/jpn.180209.
- Donaldson Z.R., Nautiyal K.M., Ahmari S.E., Hen R. Genetic approaches for understanding the role of serotonin receptors in mood and behavior. Curr. Opin. Neurobiol. 2013; 23: 399–406. doi: 10.1016/j.conb.2013.01.011.
- Kulikova E.A., Bazovkina D.V., Akulov A.E. et al. Alterations in pharmacological and behavioural responses in recombinant mouse line with an increased predisposition to catalepsy: role of the 5-HT1A receptor. Br. J. Pharmacol. 2016; 173(13): 2147–2161. doi: 10.1111/bph.13484.
- Kondaurova E.M., Rodnyy A.Y., Ilchibaeva T.V. et al. Genetic background underlying 5-Ht1a receptor functioning affects the response to fluoxetine. Int. J. Mol. Sci. 2020; 21(22): 8784. doi: 10.3390/ijms21228784.
- Richardson-Jones J.W., Craige C.P., Guiard B.P. et al. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron. 2010; 65(1): 40–52. doi: 10.1016/j.neuron.2009.12.003.
- Bach H., Arango V. Neuroanatomy of Serotonergic Abnormalities in Suicide. Dwivedi Y. (ed.). Boca Raton (FL), 2012.
- Underwood M.D., Kassir S.A., Bakalian M.J. et al. Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity. Transl. Psychiatry 2018; 8(1): 279. doi: 10.1038/s41398-018-0309-1.
- Popova N.K., Tsybko A.S., Naumenko V.S. The implication of 5-HT receptor family members in aggression, depression and suicide: similarity and difference. Int. J. Mol. Sci. 2022; 23(15): 8814. doi: 10.3390/ijms23158814.
- Ben-Efraim Y.J., Wasserman D., Wasserman J., Sokolowski M. Family-based study of HTR2A in suicide attempts: observed gene, gene × environment and parent-of-origin associations. Mol. Psychiatry. 2013; 18(7): 758–766. doi: 10.1038/mp.2012.86.
- Ghasemi A., Seifi M., Baybordi F. et al. Association between serotonin 2A receptor genetic variations, stressful life events and suicide. Gene 2018; 658: 191–197. doi: 10.1016/j.gene.2018.03.023.
- Brezo J., Bureau A., Mérette C. et al. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. Mol. Psychiatry. 2010; 15: 831–843. doi: 10.1038/mp.2009.19.
- Shinozaki G., Romanowicz M., Mrazek D.A., Kung S. HTR2A gene-child abuse interaction and association with a history of suicide attempt among Caucasian depressed psychiatric inpatients. J. Affect. Disord. 2013; 150(3): 1200–1203. doi: 10.1016/j.jad.2013.05.028.
- Juruena M.F., Gadelrab R., Cleare A.J., Young A.H. Epigenetics: a missing link between early life stress and depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2021; 109: 110231. doi: 10.1016/j.pnpbp.2020.110231.
- Ibrahim P., Almeida D., Nagy C., Turecki G. Molecular impacts of childhood abuse on the human brain. Neurobiol. Stress. 2021; 15:100343. doi: 10.1016/j.ynstr.2021.100343.
- Gerritsen L., Milaneschi Y., Vinkers C.H. et al. HPA axis genes, and their interaction with childhood maltreatment, are related to cortisol levels and stress-related phenotypes. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2017; 42: 2446–2455. doi: 10.1038/npp.2017.118.
- Wichmann S., Kirschbaum C., Böhme C., Petrowski K. Cortisol stress response in post-traumatic stress disorder, panic disorder, and major depressive disorder patients. Psychoneuroendocrinology. 2017; 83: 135–141. doi: 10.1016/j.psyneuen.2017.06.005.
- Cahir M., Ardis T., Reynolds G.P., Cooper S.J. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT2A receptor binding in the rat. Psychopharmacology (Berl). 2007; 190(4): 497–506. doi: 10.1007/s00213-006-0635-5.
- Jennings K.A., Sheward W.J., Harmar A.J., Sharp T. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function. Neuropharmacology. 2008; 54(5): 776–783. doi: 10.1016/j.neuropharm.2007.12.001.
- Jørgensen L.M., Weikop P., Villadsen J. et al. Cerebral 5-HT release correlates with [11C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain. J. Cereb. blood flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab. 2017; 37(2): 425–434. doi: 10.1177/0271678X16629483.
- Vadodaria K.C., Ji Y., Skime M. et al. Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons. Mol. Psychiatry 2019; 24: 795–807. doi: 10.1038/s41380-019-0363-y.
- Schwasinger-Schmidt T.E., Macaluso M. Other antidepressants. Handb. Exp. Pharmacol. 2019; 250: 325–355. doi: 10.1007/164_2018_167.
- Slifirski G., Król M., Turіo J. 5-HT Receptors and the development of new antidepressants. Int. J. Mol. Sci. 2021; 22(16): 9015. doi: 10.3390/ijms22169015.
- Wright B.M., Eiland E.H. 3rd, Lorenz R. Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature. Pharmacotherapy. 2013; 33: 344–359. doi: 10.1002/phar.1204.
- Guiard B.P., Di Giovanni G. Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link? Front. Pharmacol. 2015; 6: 46. doi: 10.3389/fphar.2015.00046.
- Borroto-Escuela D.O., Ambrogini P., Chruscicka B. et al. The role of central serotonin neurons and 5-HT heteroreceptor complexes in the pathophysiology of depression: a historical perspective and future prospects. Int. J. Mol. Sci. 2021; 22(4): 1927. doi: 10.3390/ijms22041927.